The Improbability of the Rapid Development of a Vaccine for SARS-CoV-2.

Morris, Kevin V

Morris, Kevin V.

Morris KV; Center for Gene Therapy, City of Hope, Beckman Research Institute and Hematological Malignancy and Stem Cell Transplantation Institute at the City of Hope, 1500 E. Duarte Rd., Duarte, CA 91010, USA; School of Medical Science, Griffith University, Gold Coast Campus, Southport, QLD 4222, Australia. Electronic address: kmorris@coh.org.

Mol Ther ; 28(7): 1548-1549, 2020 07 08.

Article in English | MEDLINE | ID: covidwho-1386764

Subject(s)

Antibody-Dependent Enhancement/immunology; Betacoronavirus/immunology; Coronavirus Infections/prevention & control; Pandemics/prevention & control; Pneumonia, Viral/prevention & control; Viral Vaccines/immunology; Animals; COVID-19; Cats; Cell- and Tissue-Based Therapy; Coronavirus Infections/virology; Coronavirus, Feline/immunology; Feline Infectious Peritonitis/immunology; Feline Infectious Peritonitis/virology; Genetic Therapy; Humans; Pneumonia, Viral/virology; SARS-CoV-2; Viral Vaccines/therapeutic use

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Viral Vaccines / Coronavirus Infections / Antibody-Dependent Enhancement / Pandemics / Betacoronavirus Topics: Vaccines Limits: Animals / Humans Language: English Journal: Mol Ther Journal subject: Molecular Biology / Therapeutics Year: 2020 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google